BeiGene
BGNE
#961
Rank
NZ$36.18 B
Marketcap
$330.76
Share price
0.49%
Change (1 day)
20.50%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Unfortunately we have no cost to borrow data for this company